Member Info for Retireby40

China is definitely our largest market snd they recognise our tech. We are embedded in 5 provinces and have another 18 to target as well as the US, EU, ROW (S Korea, India etc) and little Britain.

This is on the back of multiple installations of larger Microtox (R) CTM[vi] and OVA[vii] units in 5 of the 23 Provinces across China, since 2013.

So we have 18 more provinces to target which could generate huge revenues as well as recurring for reagents and AI. China has the potential to smash the £10m guidance on its own and without labskin!

A little premature given the app isn’t launched? Nice video though.

I was being sarcastic and the same applies to calling shares golden tickets etc. I can’t stand numpties talking corruption due to their investment being down, irritates me!

As far as here goes if we have the RNS we’re hoping for there will be demand for shares and that will drive the share price higher, it’s how it works!

Anyway, no more cliches from me!

Pure corruption we’re so low, AiM is a cesspit. Do not sell your golden tickets. Yada yada!

Hopefully the rush for shares will be after a detailed RNS. Let the content do the talking.

I imagine volume and posts will pick up next week it’s certainly quiet. I would prefer a lull snd then real interest, buy volume and new money coming in due to a detailed and positive RNS. That should mean any rise can be sustained as it will have increased on substance rather than hot air.

You can bet your bottom dollar there are a couple of posters desperate for 17th to be a damp squib with little detail and jam tomorrow and they’ll be all over here and likewise on advfn. I am confident that won’t be the case and what would be nice is if we have a decent RNS and the share price responds of for them to be able to post and say fair enough that’s positive for holders and will create value. I’m not holding my breath though.

What’s with the genuine?!

I don’t expect us to buy them but who knows. I’m also not concerned with the share sale as it wasn’t massive. That said it clearly affected sentiment negatively and caused the fall.

The most important thing is delivering so meeting or preferably exceeding expectations. With all the hype surrounding the AGM GB didn’t deliver for many although I was pleased with what was presented many clearly weren’t. There has been a lot less hype this time around which I’m much more comfortable with and I hope and expect expectations exceeded and we can move into a new share price range.

What’s important for me is delivering and all else will look after itself. What will follow is more sophisticated investors and for us to be taken more seriously which is important for this year. Come YE I’m expecting to have had many TR1s and a much healthier large shareholder list.

Looking at the co when GB took over the turnaround has been superb and now we need to push on and get well beyond £50m market cap and I believe come end of H1 we’ll be nearer to £100m market cap than £50m even.

This is my largest holding (although AVCT catching up!) and I expect this to multibag for me like my 3 other investments have. To be honest I expected DVRG to before the others.

I expect PD to be in high demand and think this will push us to the next level.

I agree and all the noise suggests affimers are better than Optimers which is why avacta is getting such deals for their use and with very large and established diagnostics businesses. They would have tested them extensively so clearly the performance is better.

No way as that’s material and would have to be published in an RNS ASAP.

I think once bitten twice shy prongs to mind. Most of us LTHs have done our research and are confident (even without PD or BT as labskin and MWG great) but those on the outside I believe are sceptical given the supposed pump and dump last time. We’ve had £3.6m confirmed orders for MWG which is nearly last year’s revenue and we’re still below where Mrs B sold a month ago, that seemingly withdrew the momentum we were building. The market is a crazy place and can be illogical but it gave many sceptics ammunition. I believe we will see some buying volume before Weds and I hope if we do spike the details in the RNS are enough to sustain any share price rise. I’m sure the boss knows this and will want to deliver as I believe there are many doubters which is reflected in the share price and lack of institutional interest which I believe will change some H2 when we’ve been comfortably over £50m market cap for several weeks.

The app isn’t yet launched and I imagine we’ve only soft launched but I take your point maybe an RNS isn’t needed. A shame though as we’re only just in the 30s. The main thing is a detailed RNS on testing and the share price will take care of itself.

In AVCT? This isn’t a cross-ramp and we’re connected to them as use their Affimers but just wondering as that’s just as exciting as here (and that’s ignoring their therapeutic division which could change cancer treatment).

I was lucky to start buying at 32p nearly a year ago and a mate didn’t wanna buy as they quickly moved to 40p. Dear oh dear!

Anyway, back to here and assuming we launch the PD in the coming weeks I expect us to be nearer to 100p than 30p and in no time at all. Now is the time to buy here!

Well we’re certainly busy recruiting which is really positive but I think we need to be realistic re BT. I believe there will be many more hurdles before commercialisation so even if test results are good i wouldn’t expect roll out in a matter of weeks but a couple of months. That said I expect PD to be rolled out quickly and some really positive coverage and orders, if this is a world first (as I believe) it will surely sell itself and put DVRG on many a radar both from a commercial/sales point of view but also as an investment.

Ideally we’d have skintrustclub official launch RNS tomorrow or Friday ahead of the RNS and proactive video on Weds. Much better for the big RNS to land when we have even more momentum.

Remember end of March last year we said we had orders of £2m so given we’ve had £3.6m for MWG I expect us to be near to £7.5m as labskin is surely double where it was this time last year? Whether they RNS that who knows but we are certainly building.

Yeah I forgot GB stated - Always working way ahead. March already here, just a launch of @skintrustclub club and results of COVID19 tests in UK and China

So I expect results next week, wow and surely they have a good idea whether they’re positive or not so surely they’re good. Crazy we’re still 10% down from a month ago. I’m sure the buy volume will increase ahead of next week and I really hope it’s not a damp squib like the AGM. I’ve no doubt GB has learnt his lesson and the re-rate will commence.

It’d be good to have the skintrustclub official launch (with app) beforehand and get some momentum.

Paul, I wasn’t implying we’d get financial news but I think we’re all expecting testing to have been completed so I guess with that comes next steps. I expect the wastewater testing to be complete and we can start selling as a real-time covid detection solution but the BT will need to jump through more hoops I imagine. Exciting and imagine the publicity if we have the world’s first real-time Covid (amongst many targets) wastewater detection units. Anyway, let’s not get ahead of ourselves but exciting times.

Posted on twitter -

https://bidstats.uk/tenders/2021/W05/744358096

What I like is the start date, surely we’ll be ready to rock snd roll and once in place it’ll be recurring revenue and a great case study! I’m jumping to conclusions here but we surely (all being well with testing) have the best solution here!?

How do we know for sure we’re getting a material update (so RNS) rather than RNS reach and proactive video? Anything material needs to be published ASAP so I assume if there is an RNS with test results it’s because they’ve decided on a cut off point so testing is driven by time. I imagine LFTs etc will need a certain sample number ie 500 negative and 500 positive for sensitivity/specificity but it’s hard to know exactly when you’ll reach the sample size. Just musing re giving a date (17 March) if it’s results we’re publishing. If so it’s time/data collection which I understand for PD (wastewater) but am less certain re BT.

With PD (am so excited by this!) we can predict spikes in communities and the testing data will hopefully demonstrate that a couple of weeks later so I assume the BT is used in conjunction with PCR tests?

Am brimming with excitement and intrigued as to how this will be presented. Just over a week to go!

A buyout would be amazing but in the immediate term successful test results will be amazing and lead to a spike but in order to sustain and go even higher a clear roadmap as to how we plan to maximise the opportunity in the near and medium term. I imagine impressive results will mean demand will be massive so can we fulfil this ourselves or do we use more partners etc? Anyway, beforehand I expect a skintrustclub RNS confirming full launch to whet the appetite ahead of the big one.